.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,635,268

« Back to Dashboard

Details for Patent: 6,635,268

Title: Sustained delivery of an active agent using an implantable system
Abstract:The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.
Inventor(s): Peery; John R. (Stanford, CA), Dionne; Keith E. (Menlo Park, CA), Eckenhoff; James B. (Los Altos, CA), Landrau; Felix A. (Punta Gorda, FL), Lautenbach; Scott D. (San Mateo, CA), Magruder; Judy A. (Mountain View, CA), Wright; Jeremy C. (Los Altos, CA)
Assignee: Alza Corporation (Mountain View, CA)
Filing Date:Mar 28, 2002
Application Number:10/108,303
Claims:1. An implantable device for delivering an active agent to a fluid environment of use for a predetermined administration period of at least 2 months, said device comprising a reservoir and a back-diffusion regulating outlet in mating relationship, wherein a flow path for the active agent comprises a pathway formed between the mating surfaces of the reservoir and the back-diffusion regulating outlet.

2. The device of claim 1 wherein a time to start-up is less than 10% of the predetermined administration period.

3. The device of claim 1 wherein the predetermined administration period is at least 3 months.

4. The device of claim 3 wherein a time to start-up is less than 10% of the predetermined administration period.

5. The device of claim 1 wherein the predetermined administration period is at least 12 months.

6. The device of claim 5 wherein a time to start-up is less than 10% of the predetermined administration period.

7. The device of claim 1 wherein the device maintains at least 70% activity for the predetermined administration period.

8. The device of claim 1 wherein the device maintains at least 70% activity for 14 months.

9. The device of claim 1 wherein the device provides a steady state flow rate of at least 70% of an intended flow rate after start-up.

10. An implantable active agent delivery system for delivering an active agent to a fluid environment of use for a predetermined administration period of at least 2 months, said agent being susceptible to degradation if exposed to the fluid environment of use prior to delivery, said system comprising: (a) a piston that divides the system into a first and second chamber, the first and second chambers each having an open end; (b) a water-swellable agent formulation in the first chamber; (c) an active agent formulation in the second chamber; (d) a semipermeable plug in the open end of the first chamber; and (e) a back-diffusion regulating outlet in the open end of the second chamber; wherein said system effectively seals and isolates the active agent chamber from the environment of use.

11. The system of claim 10 wherein said system expels the active agent through the outlet at a rate corresponding to a rate at which water from the environment flows into the water-swellable agent.

12. The system of claim 10 wherein a time to start-up is less than 10% of the predetermined administration period.

13. The system of claim 10 wherein the predetermined administration period is at least 3 months.

14. The system of claim 13 wherein a time to start-up is less than 10% of the predetermined administration period.

15. The system of claim 10 wherein the predetermined administration period is at least 12 months.

16. The system of claim 15 wherein a time to start-up is less than 10% of the predetermined administration period.

17. The system of claim 10 wherein the system maintains at least 70% activity for the predetermined administration period.

18. The system of claim 10 wherein the system maintains at least 70% activity for 14 months.

19. The system of claim 10 wherein the system provides a steady state flow rate of at least 70% of an intended flow rate after start-up.

20. An implantable active agent delivery system for delivering an active agent to a fluid environment of use at a steady state flow rate of at least 70% of an intended flow rate after start-up, said agent being susceptible to degradation if exposed to the fluid environment of use prior to delivery, said system comprising: (a) a piston that divides the system into a first and second chamber, the first and second chambers each having an open end; (b) a water-swellable agent formulation in the first chamber; (c) an active agent formulation in the second chamber; (d) a semipermeable plug in the open end of the first chamber; and (e) a back-diffusion regulating outlet in the open end of the second chamber; wherein said system effectively seals and isolates the active agent chamber from the environment of use.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc